Penetrance of CHEK2 and BRCA1 Double Heterozygotes in Breast and/or Ovarian Cancer Patients Cover

.blurhash-client-img { display: none !important; }

Penetrance of CHEK2 and BRCA1 Double Heterozygotes in Breast and/or Ovarian Cancer Patients

Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.

Volume 77 (2023): Issue 2 (April 2023)

By: Egija Berga-Švītiņa, Valdis Pirsko, Miki Nakazawa-Miklaševiča, Jeļena Maksimenko, Jānis Gardovskis and Edvīns Miklaševičs

Open Access

|May 2023

Authors

Egija Berga-Švītiņa

egija.berga-svitina@rsu.lv

Institute of Oncology, Rīga Stradiņš University, Latvia

Valdis Pirsko

Institute of Oncology, Rīga Stradiņš University, Latvia

Miki Nakazawa-Miklaševiča

Institute of Oncology, Rīga Stradiņš University, Latvia

Faculty of Medicine, Rīga Stradiņš University, Latvia

Jeļena Maksimenko

Institute of Oncology, Rīga Stradiņš University, Latvia

Faculty of Medicine, Rīga Stradiņš University, Latvia

Pauls Stradiņš Clinical University Hospital, Latvia

Jānis Gardovskis

Institute of Oncology, Rīga Stradiņš University, Latvia

Faculty of Medicine, Rīga Stradiņš University, Latvia

Pauls Stradiņš Clinical University Hospital, Latvia

Edvīns Miklaševičs

Institute of Oncology, Rīga Stradiņš University, Latvia

Faculty of Medicine, Rīga Stradiņš University, Latvia

DOI: https://doi.org/10.2478/prolas-2023-0020 | Journal eISSN: 2255-890X | Journal ISSN: 1407-009X

Journal RSS Feed

Language: English

Page range: 137 - 140

Submitted on: Nov 1, 2021

|

Accepted on: Feb 8, 2023

|

Published on: May 18, 2023

Published by: Latvian Academy of Sciences

In partnership with: Paradigm Publishing Services

Publication frequency: 6 issues per year

Keywords:

pathogenic variant carriers,

double heterozygote,

Related subjects:

General interest,

General mathematics

© 2023 Egija Berga-Švītiņa, Valdis Pirsko, Miki Nakazawa-Miklaševiča, Jeļena Maksimenko, Jānis Gardovskis, Edvīns Miklaševičs, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous article Volume 77 (2023): Issue 2 (April 2023)